Itf Pharma Inc recalls Tiglutik (riluzole) Oral Suspension 50 mg/10 mL (5 mg/mL)
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Failed Viscosity Specifications: Out-of-specification test results for viscosity
- Products
-
- Tiglutik (riluzole) Oral Suspension 50 mg/10 mL (5 mg/mL)
- Company
- Itf Pharma Inc
- Where it was sold
-
Distributed to one distributor in TN who may have further distributed.
States: Tennessee
- Units affected
- 1,792 bottles
- About this recall
- Tiglutik (riluzole) Oral Suspension 50 mg/10 mL (5 mg/mL), 600 mL (two bottles/300 mL each), RX only, Manufactured for ITF Pharma, Inc., Berwyn, PA 19312 USA NDC:70726-0303-1 (carton) and 70726-0303-2 (bottle)